Enhanced miR-9 promotes laryngocarcinoma cell survival via down-regulating PTEN

被引:14
|
作者
Lu, Eryong
Su, Jili
Zeng, Wei
Zhang, Chao [1 ,2 ]
机构
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, 24 Jing Hua Rd, Luoyang 471003, Peoples R China
[2] Henan Univ Sci & Technol, Coll Clin Med, Luoyang 471003, Peoples R China
关键词
Laryngocarcinoma; PTEN; MiR-9; TUMOR-SUPPRESSOR; PROLIFERATION; CANCER; CARCINOMA; MICRORNA-9; INVASION; BIOMARKERS; ACTIVATION; EXPRESSION; TARGETS;
D O I
10.1016/j.biopha.2016.09.047
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
MicroRNAs (miRNAs) play important roles in gene regulation during laryngocarcinoma. MiR-9 is a potential oncomiR, but its function in laryngocarcinoma is not known. The aim of this study is to investigate the roles of miR-9 in laryngocarcinoma. We found miR-9 expression was higher in laryngocarcinoma tissues compared with their normal controls, so did the laryngocarcinoma cells. Cellular function of miR-9 indicated that miR-9 restoration in laryngocarcinoma cells could promote cell proliferation and metastasis. Phosphatase and tensin homolog (PTEN) was predicted as a target gene of miR-9 and verified using luciferase reporter assay. PTEN expression was down-regulated in the laryngocarcinoma cells with miR-9 overexpression. We also found that miR-9 expression was negatively associated with PTEN expression in laryngocarcinoma tissues. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:608 / 613
页数:6
相关论文
共 50 条
  • [21] Circ100284 promotes invasion and migration of osteosarcoma cells by down-regulating PTEN and EMP1
    Liu, Y-D
    Liu, L-P
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (12) : 6540 - 6550
  • [22] MicroRNA-221 promotes myocardial apoptosis caused by myocardial ischemia-reperfusion by down-regulating PTEN
    Kong, Q-R
    Ji, D-M
    Li, F-R
    Sun, H-Y
    Wang, Q-X
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 3967 - 3975
  • [23] miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
    Yong Zhou
    Zufa Huang
    Song Wu
    Xiaofang Zang
    Min Liu
    Jian Shi
    Journal of Experimental & Clinical Cancer Research, 33
  • [24] miR-29a promotes myocardial cell apoptosis induced by high glucose through down-regulating IGF-1
    Han, Chunli
    Chen, Xiaochao
    Zhuang, Renwei
    Xu, Mingtong
    Liu, Shulei
    Li, Qiwen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 14352 - 14362
  • [25] miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST
    Zhou, Yong
    Huang, Zufa
    Wu, Song
    Zang, Xiaofang
    Liu, Min
    Shi, Jian
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
  • [26] MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer
    Xia, Haifeng
    Chen, Shaomu
    Chen, Ke
    Huang, Haitao
    Ma, Haitao
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (08) : 951 - 958
  • [27] Helicobacter pylori induces gastric cancer via down-regulating miR-375 to inhibit dendritic cell maturation
    Zhang, Zhenxing
    Chen, Simiao
    Fan, Menghui
    Ruan, Guojing
    Xi, Tao
    Zheng, Lufeng
    Guo, Le
    Ye, Feng
    Xing, Yingying
    HELICOBACTER, 2021, 26 (04)
  • [28] MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1
    D.-Z. Liu
    B. Chang
    X.-D. Li
    Q.-H. Zhang
    Y.-H. Zou
    Clinical and Translational Oncology, 2017, 19 : 1133 - 1140
  • [29] MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1
    Liu, D. -Z.
    Chang, B.
    Li, X. -D.
    Zhang, Q. -H.
    Zou, Y. -H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (09): : 1133 - 1140
  • [30] Reduced miR-9 and miR-181a expression down-regulates Bim concentration and promote osteoclasts survival
    Wang, Shilong
    Tang, Chaoliang
    Zhang, Quan
    Chen, Wenjun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2209 - 2218